SEC Company Response from PDS Biotechnology Corp (PDSB) (CIK 0001472091) (PDSB) — Aug 26, 2019

PDS Biotechnology Corp (PDSB) (CIK 0001472091)
Date: Aug. 26, 2019 · CIK: 0001472091 · Accession: 0001140361-19-015612

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-232988

Date

August 26, 2019

Author

Assistant Director

Form

CORRESP

Company

PDS Biotechnology Corp (PDSB) (CIK 0001472091)

Letter

PDS Biotechnology Corporation

300 Connell Drive, Suite 4000

Berkeley Heights, New Jersey 07922

August 26, 2019

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549-4561

Attention:

Suzanne Hayes

Assistant Director

Re: PDS Biotechnology Corporation

Registration Statement on Form S-1

File No. 333-232988

Ladies and Gentleman:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, PDS Biotechnology Corporation hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-232988) (the “Registration Statement”), so that the Registration Statement may become effective at 4:30 p.m. (Washington, D.C. time) on August 28, 2019 or as soon as practicable thereafter.

PDS BIOTECHNOLOGY CORPORATION

By: /s/ Andrew Saik

Name: Andrew Saik

Title: Chief Financial Officer

Show Raw Text

CORRESP
1
filename1.htm

    PDS Biotechnology Corporation

    300 Connell Drive, Suite 4000

    Berkeley Heights, New Jersey 07922

    August 26, 2019

    VIA EDGAR

    Securities and Exchange Commission

    Division of Corporation Finance

    100 F Street, N.E.

    Washington, DC 20549-4561

            Attention:

            Suzanne Hayes

            Assistant Director

    Re: PDS Biotechnology Corporation

    Registration Statement on Form S-1

    File No. 333-232988

    Ladies and Gentleman:

    Pursuant to Rule 461 under the Securities Act of 1933, as amended, PDS Biotechnology Corporation hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No.
      333-232988) (the “Registration Statement”), so that the Registration Statement may become effective at 4:30 p.m. (Washington, D.C. time) on August 28, 2019 or as soon as practicable thereafter.

            PDS BIOTECHNOLOGY CORPORATION

            By:  /s/ Andrew Saik

            Name: Andrew Saik

            Title: Chief Financial Officer

SecProbe.io